Zinforo is indicated for the treatment of the following infections caused by susceptible isolates of the designated microorganisms: Complicated skin and soft tissue infections (cSSTI); Community-acquired pneumonia (CAP).
Zinforo is indicated in neonates, infants, children, adolescents and adults.